로딩 중…
지수 로딩 중…
Rocket Pharmaceuticals, Inc.
RCKT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.35+6.01%
2026-06-18
Price Chart
Rocket Pharmaceuticals, Inc.+18.37%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $366M |
| Revenue | $0.00 |
| Net Income | $-209M |
| Total Assets | $285M |
| Net Assets | $238M |
| Value | |
| P/B | 1.54x |
| FCF Yield | -49.15% |
| Profitability | |
| ROE | -87.96% |
| ROA | -73.36% |
| Financial Health | |
| Debt Ratio | 19.90% |
| Total Debt | $25M |
| FCF | $-180M |
| Cash | $50M |
| Current Ratio | 6.12x |
| Performance | |
| 1Y Return | 18.37% |
| 1M Return | 14.73% |
| From 52W High | -38.53% |
| 1Y MDD | -70.01% |
| Trading | |
| Volume | 8,172,624 shares |
| Trading Value | $27M |
| Per Share | |
| EPS | $-2.01 |
| BPS | $2.49 |